SUBSCRIBE
SUBSCRIBE
News   Deals

Ipsen Aims To Raise €400 Million In IPO

November 23, 2005 | 
1 min read
Ipsen, the French pharmaceuticals company, yesterday unveiled plans to raise about €400m ($470m) in an initial public offering, which would reduce the stake of the family of founder Henri Beaufour and raise funds for research.
IPO Europe
Ipsen Biopharmaceuticals, Inc.
MORE ON THIS TOPIC
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Generate Clocks Largest IPO Since 2024 With $400M Raise
February 27, 2026
 · 
5 min read
 · 
Tristan Manalac
Control, Complex work, Businessman balancing on a ball
Deals
Boehringer Seeks To Rebalance Immunity With Sitryx Collab Potentially Worth $500M+
February 26, 2026
 · 
1 min read
 · 
Tristan Manalac
change one's mind, decision, direction
Gene editing
Pfizer Advances Beam’s Gene Editor After Pulling Hemophilia Gene Therapy
February 26, 2026
 · 
1 min read
 · 
Tristan Manalac
A pill bottle in between two injector pens
Weight loss
Novo Leans Into Oral Route With Weight Loss Partnership Worth up to $2.1B
February 25, 2026
 · 
2 min read
 · 
Tristan Manalac